Skip to the record

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 3 May 2026

Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.

Scope · likely financings by canton

43 likely financings · 4 Apr 2026 – 3 May 2026 · the feed below shows one weekZH ✕ show all cantonsMap: Natural Earth

Likely financing: Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided: Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased: No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round: A financing announcement on startupticker.ch names the company and matches this increase.

Published 27 Apr – 3 May 2026 · canton ZH

25 capital increases · 3 shown

Capital increases published 27 Apr – 3 May 2026
Company	Status	Nominal share capital (CHF) before → after	New shares, % of post-step shares	Announced roundnot disclosed in the SHAB	SHAB published	Source
OxyPrem AGZH · Die Gesellschaft bezweckt die Entwicklung, Herstellung und den Verkauf von Produkten auf dem Gebiete der …SHAB publication HR02-1006639830	Likely financingscore 0.60	158’511 → 167’054New shares 5.1%	5.1%	—	1 May 2026	SHAB publication HR02-1006639830
Anapaya Systems AGZH · Die Gesellschaft bezweckt die Konzeption, Entwicklung und den Betrieb von IT gestützten Produkten und …SHAB publication HR02-1006636177	Likely financingscore 0.93	260’825 → 289’054.20New shares 9.8%	9.8%	—	28 Apr 2026	SHAB publication HR02-1006636177
Cultivated Biosciences SAZH · Zweck der Gesellschaft ist die Forschung und Entwicklung auf dem Gebiet der Lebensmitteltechnologie und der …SHAB publication HR02-1006634955	Likely financingscore 0.96	199’083.90 → 281’247.50New shares 29.2%	29.2%	—	27 Apr 2026	SHAB publication HR02-1006634955

22 other capital increases published this week ▸